Profound Medical (PROF)
(Delayed Data from NSDQ)
$8.01 USD
-0.19 (-2.32%)
Updated Sep 9, 2024 03:59 PM ET
After-Market: $8.01 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 39% (98 out of 249)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.58 | 9.99 |
Current Quarter Estimate | -0.31 | -1.21 | 61.00 |
Year Ago Quarter Estimate | -0.26 | -0.06 | 54.84 |
Next Quarter Estimate | -0.33 | -1.94 | 63.00 |
Next Year Estimate | -0.85 | 12.55 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 16.30 | 20.50 | 15.67 |
Next Year | 24.78 | 15.10 | 11.34 |
Last 5 Years | NA | 7.90 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.62 |
Price/Book (MRQ) | 5.12 | 1.59 |
Price/Cash Flow (MRFY) | NA | 9.36 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -350.14% | -61.35% |
Return on Equity (TTM) | -71.28% | -58.93% |
Debt to Equity (MRQ) | 0.10 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.